Ethan Lange
Concepts (687)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 44 | 2016 | 1016 | 3.410 |
Why?
| Genetic Linkage | 41 | 2012 | 299 | 3.090 |
Why?
| Polymorphism, Single Nucleotide | 65 | 2025 | 2064 | 3.040 |
Why?
| Genetic Predisposition to Disease | 68 | 2025 | 2269 | 2.910 |
Why?
| Genome-Wide Association Study | 46 | 2025 | 1332 | 2.660 |
Why?
| Genotype | 52 | 2023 | 1830 | 1.440 |
Why?
| Genome, Human | 17 | 2020 | 392 | 1.360 |
Why?
| Gene Frequency | 33 | 2022 | 504 | 1.340 |
Why?
| Genetic Variation | 26 | 2021 | 935 | 1.210 |
Why?
| Chromosomes, Human, Pair 17 | 11 | 2019 | 54 | 0.970 |
Why?
| Cardiovascular Diseases | 17 | 2022 | 2001 | 0.960 |
Why?
| Exome | 9 | 2016 | 220 | 0.900 |
Why?
| Body Mass Index | 18 | 2025 | 2263 | 0.860 |
Why?
| Obesity | 16 | 2025 | 2864 | 0.830 |
Why?
| Alleles | 21 | 2025 | 842 | 0.830 |
Why?
| Haplotypes | 26 | 2016 | 471 | 0.800 |
Why?
| Chromosome Mapping | 25 | 2010 | 504 | 0.790 |
Why?
| Genetic Loci | 10 | 2019 | 275 | 0.730 |
Why?
| Hypertension | 7 | 2022 | 1236 | 0.720 |
Why?
| Models, Genetic | 14 | 2022 | 593 | 0.710 |
Why?
| Male | 137 | 2025 | 63043 | 0.680 |
Why?
| Pedigree | 25 | 2016 | 485 | 0.650 |
Why?
| Sickle Cell Trait | 4 | 2020 | 13 | 0.630 |
Why?
| Humans | 189 | 2025 | 128495 | 0.630 |
Why?
| Middle Aged | 80 | 2025 | 30921 | 0.620 |
Why?
| Polymorphism, Genetic | 9 | 2009 | 639 | 0.620 |
Why?
| Genetic Association Studies | 9 | 2022 | 361 | 0.610 |
Why?
| Aged | 71 | 2024 | 21974 | 0.590 |
Why?
| Chromosomes, Human, Pair 8 | 5 | 2019 | 35 | 0.590 |
Why?
| Apolipoproteins E | 3 | 2015 | 77 | 0.530 |
Why?
| Phenotype | 26 | 2021 | 3051 | 0.530 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2015 | 51 | 0.510 |
Why?
| Adult | 74 | 2025 | 35299 | 0.490 |
Why?
| Female | 113 | 2025 | 68266 | 0.490 |
Why?
| Chromosomes, Human, Pair 11 | 11 | 2011 | 56 | 0.490 |
Why?
| Fibroblast Growth Factor 5 | 1 | 2015 | 2 | 0.480 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 10 | 0.480 |
Why?
| Lipoprotein(a) | 1 | 2015 | 67 | 0.470 |
Why?
| Transferrin | 1 | 2014 | 42 | 0.460 |
Why?
| Trinucleotide Repeats | 2 | 2008 | 25 | 0.460 |
Why?
| Ferritins | 1 | 2014 | 58 | 0.460 |
Why?
| Quantitative Trait, Heritable | 9 | 2021 | 120 | 0.450 |
Why?
| src-Family Kinases | 1 | 2015 | 95 | 0.450 |
Why?
| Receptors, Androgen | 3 | 2017 | 143 | 0.450 |
Why?
| Diabetes Mellitus, Type 2 | 10 | 2023 | 2433 | 0.450 |
Why?
| Anemia, Iron-Deficiency | 1 | 2014 | 57 | 0.430 |
Why?
| Family Health | 10 | 2017 | 195 | 0.430 |
Why?
| Quantitative Trait Loci | 9 | 2022 | 355 | 0.430 |
Why?
| Blood Pressure | 5 | 2020 | 1712 | 0.420 |
Why?
| Fibrin Fibrinogen Degradation Products | 2 | 2017 | 83 | 0.410 |
Why?
| Renal Insufficiency, Chronic | 3 | 2024 | 564 | 0.410 |
Why?
| Lod Score | 16 | 2011 | 66 | 0.410 |
Why?
| Ataxia Telangiectasia | 10 | 2004 | 17 | 0.400 |
Why?
| Iron | 1 | 2014 | 282 | 0.390 |
Why?
| Whole Genome Sequencing | 2 | 2025 | 130 | 0.390 |
Why?
| Microsatellite Repeats | 11 | 2012 | 161 | 0.380 |
Why?
| Receptors, Urokinase Plasminogen Activator | 2 | 2021 | 14 | 0.370 |
Why?
| Blood Coagulation | 2 | 2015 | 236 | 0.360 |
Why?
| Risk Factors | 26 | 2024 | 9737 | 0.360 |
Why?
| Cohort Studies | 22 | 2020 | 5402 | 0.350 |
Why?
| Control Groups | 1 | 2010 | 11 | 0.350 |
Why?
| Proteins | 7 | 2022 | 936 | 0.350 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2010 | 18 | 0.350 |
Why?
| Weight Gain | 5 | 2016 | 504 | 0.350 |
Why?
| Longitudinal Studies | 15 | 2022 | 2710 | 0.340 |
Why?
| X Chromosome | 2 | 2000 | 51 | 0.330 |
Why?
| Genes, BRCA1 | 3 | 2004 | 32 | 0.330 |
Why?
| Costs and Cost Analysis | 1 | 2010 | 200 | 0.330 |
Why?
| Germ-Line Mutation | 6 | 2020 | 138 | 0.320 |
Why?
| Genetics, Population | 8 | 2021 | 200 | 0.320 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 30 | 0.320 |
Why?
| Malocclusion, Angle Class III | 1 | 2009 | 2 | 0.320 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 63 | 0.320 |
Why?
| C-Reactive Protein | 5 | 2020 | 398 | 0.310 |
Why?
| Glomerular Filtration Rate | 5 | 2024 | 684 | 0.310 |
Why?
| Linkage Disequilibrium | 12 | 2017 | 257 | 0.310 |
Why?
| Atherosclerosis | 4 | 2022 | 403 | 0.300 |
Why?
| Genetic Markers | 19 | 2017 | 338 | 0.290 |
Why?
| Tumor Suppressor Proteins | 5 | 2016 | 313 | 0.290 |
Why?
| Alzheimer Disease | 2 | 2023 | 517 | 0.270 |
Why?
| Adiponectin | 5 | 2011 | 234 | 0.270 |
Why?
| Lipopolysaccharide Receptors | 2 | 2021 | 87 | 0.270 |
Why?
| Veterans | 3 | 2023 | 1397 | 0.270 |
Why?
| Young Adult | 23 | 2020 | 12349 | 0.270 |
Why?
| Case-Control Studies | 16 | 2023 | 3339 | 0.260 |
Why?
| CpG Islands | 2 | 2024 | 153 | 0.260 |
Why?
| Fibrinolysis | 1 | 2008 | 137 | 0.260 |
Why?
| Genetic Pleiotropy | 2 | 2016 | 29 | 0.260 |
Why?
| Age of Onset | 6 | 2014 | 495 | 0.260 |
Why?
| Atrial Fibrillation | 2 | 2022 | 375 | 0.260 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2006 | 56 | 0.250 |
Why?
| Kidney | 3 | 2023 | 1310 | 0.250 |
Why?
| Mutation, Missense | 7 | 2018 | 315 | 0.240 |
Why?
| Chromosomes, Human, Pair 20 | 4 | 2011 | 16 | 0.240 |
Why?
| Mendelian Randomization Analysis | 2 | 2023 | 47 | 0.240 |
Why?
| Apolipoprotein L1 | 2 | 2023 | 13 | 0.230 |
Why?
| Genetic Techniques | 2 | 2004 | 63 | 0.230 |
Why?
| Inheritance Patterns | 1 | 2004 | 46 | 0.230 |
Why?
| Sequence Analysis, DNA | 7 | 2016 | 775 | 0.220 |
Why?
| Fasting | 4 | 2018 | 264 | 0.220 |
Why?
| DNA Methylation | 3 | 2024 | 607 | 0.220 |
Why?
| Homocysteine | 2 | 2018 | 149 | 0.220 |
Why?
| United States | 24 | 2020 | 13840 | 0.220 |
Why?
| Coronary Artery Disease | 4 | 2018 | 676 | 0.220 |
Why?
| Genetics | 1 | 2004 | 25 | 0.220 |
Why?
| Blood Glucose | 6 | 2021 | 2092 | 0.210 |
Why?
| Glomerulosclerosis, Focal Segmental | 1 | 2023 | 42 | 0.210 |
Why?
| Prospective Studies | 14 | 2021 | 7069 | 0.210 |
Why?
| Homeodomain Proteins | 3 | 2012 | 489 | 0.210 |
Why?
| Mississippi | 3 | 2021 | 21 | 0.210 |
Why?
| Chromosomes, Human, Pair 1 | 5 | 2009 | 71 | 0.210 |
Why?
| Chronic Periodontitis | 2 | 2013 | 5 | 0.210 |
Why?
| Nuclear Proteins | 3 | 2014 | 658 | 0.200 |
Why?
| Dementia, Vascular | 1 | 2022 | 18 | 0.200 |
Why?
| Aged, 80 and over | 16 | 2020 | 7057 | 0.200 |
Why?
| Software | 4 | 2016 | 608 | 0.200 |
Why?
| Diabetic Neuropathies | 1 | 2023 | 86 | 0.200 |
Why?
| DNA, Neoplasm | 5 | 2014 | 159 | 0.200 |
Why?
| Polymerase Chain Reaction | 8 | 2012 | 1027 | 0.190 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2022 | 126 | 0.190 |
Why?
| Smoking | 2 | 2021 | 1459 | 0.190 |
Why?
| Adolescent | 28 | 2023 | 20304 | 0.190 |
Why?
| Aging, Premature | 1 | 2021 | 13 | 0.190 |
Why?
| Cell Transformation, Neoplastic | 2 | 2020 | 325 | 0.180 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 35 | 0.180 |
Why?
| Age Factors | 12 | 2021 | 3122 | 0.180 |
Why?
| Chromosomes, Human, X | 3 | 2015 | 72 | 0.180 |
Why?
| Risk Assessment | 11 | 2021 | 3232 | 0.180 |
Why?
| Linear Models | 4 | 2021 | 816 | 0.180 |
Why?
| Receptors, Adiponectin | 2 | 2011 | 19 | 0.180 |
Why?
| Nutrition Surveys | 4 | 2018 | 261 | 0.170 |
Why?
| Carcinoma | 3 | 2010 | 215 | 0.170 |
Why?
| Mutation | 9 | 2014 | 3696 | 0.170 |
Why?
| Epigenomics | 1 | 2021 | 110 | 0.170 |
Why?
| Epigenesis, Genetic | 2 | 2024 | 614 | 0.170 |
Why?
| Prognosis | 9 | 2021 | 3780 | 0.170 |
Why?
| Chemokine CXCL10 | 1 | 2020 | 34 | 0.170 |
Why?
| Antigens, CD | 1 | 2022 | 482 | 0.170 |
Why?
| Zinc Fingers | 2 | 2017 | 44 | 0.170 |
Why?
| Lymphadenopathy | 1 | 2019 | 8 | 0.170 |
Why?
| Statistics, Nonparametric | 4 | 2017 | 419 | 0.160 |
Why?
| Biomarkers | 7 | 2023 | 3893 | 0.160 |
Why?
| Adiposity | 2 | 2017 | 504 | 0.160 |
Why?
| Factor VIII | 1 | 2020 | 85 | 0.160 |
Why?
| Exercise | 4 | 2016 | 1918 | 0.160 |
Why?
| DNA-Binding Proteins | 7 | 2020 | 1423 | 0.160 |
Why?
| Computer Simulation | 6 | 2021 | 939 | 0.160 |
Why?
| Genetic Testing | 4 | 2009 | 428 | 0.160 |
Why?
| Repressor Proteins | 3 | 2014 | 401 | 0.160 |
Why?
| Pediatric Obesity | 2 | 2017 | 570 | 0.160 |
Why?
| Renal Insufficiency | 1 | 2021 | 148 | 0.160 |
Why?
| International Cooperation | 5 | 2011 | 173 | 0.160 |
Why?
| Mortality | 1 | 2021 | 306 | 0.160 |
Why?
| Trabeculectomy | 1 | 2000 | 71 | 0.160 |
Why?
| Epidemiologic Studies | 1 | 2019 | 65 | 0.150 |
Why?
| Neoplasm, Residual | 1 | 2019 | 119 | 0.150 |
Why?
| Incidence | 7 | 2021 | 2638 | 0.150 |
Why?
| Cell Cycle Proteins | 4 | 2015 | 581 | 0.150 |
Why?
| Lymphoma | 1 | 2020 | 195 | 0.150 |
Why?
| Adolescent Health | 2 | 2015 | 39 | 0.150 |
Why?
| Fibrinogen | 2 | 2010 | 164 | 0.150 |
Why?
| alpha-Globins | 1 | 2018 | 9 | 0.150 |
Why?
| Child | 19 | 2022 | 20805 | 0.150 |
Why?
| Hemoglobin, Sickle | 1 | 2018 | 18 | 0.150 |
Why?
| Observational Studies as Topic | 1 | 2019 | 108 | 0.150 |
Why?
| China | 2 | 2018 | 190 | 0.150 |
Why?
| Thromboplastin | 2 | 2017 | 70 | 0.150 |
Why?
| Brain Ischemia | 2 | 2015 | 310 | 0.150 |
Why?
| Gene Pool | 1 | 2017 | 5 | 0.150 |
Why?
| Antithrombin III | 1 | 2017 | 8 | 0.150 |
Why?
| Proportional Hazards Models | 7 | 2020 | 1200 | 0.150 |
Why?
| Receptors, LDL | 2 | 2014 | 46 | 0.140 |
Why?
| Health Surveys | 2 | 2018 | 493 | 0.140 |
Why?
| Hemoglobins, Abnormal | 1 | 2017 | 9 | 0.140 |
Why?
| Mitral Valve Prolapse | 1 | 2017 | 9 | 0.140 |
Why?
| Factor VIIa | 1 | 2017 | 39 | 0.140 |
Why?
| Proteome | 1 | 2022 | 432 | 0.140 |
Why?
| Gene Expression | 1 | 2022 | 1455 | 0.140 |
Why?
| Fatty Liver | 1 | 2020 | 231 | 0.140 |
Why?
| Asthma | 5 | 2019 | 2213 | 0.140 |
Why?
| Body Height | 2 | 2017 | 193 | 0.140 |
Why?
| Leukocytes | 2 | 2016 | 303 | 0.140 |
Why?
| Blood Platelets | 2 | 2016 | 377 | 0.140 |
Why?
| Glaucoma | 1 | 2000 | 219 | 0.130 |
Why?
| Interferon-gamma | 1 | 2020 | 761 | 0.130 |
Why?
| Schizophrenia | 5 | 2007 | 428 | 0.130 |
Why?
| Cadmium | 1 | 2016 | 67 | 0.130 |
Why?
| Erythropoiesis | 1 | 2016 | 51 | 0.130 |
Why?
| Immune System Diseases | 1 | 2016 | 35 | 0.130 |
Why?
| Antihypertensive Agents | 1 | 2020 | 482 | 0.130 |
Why?
| Insulin-Like Growth Factor I | 2 | 2009 | 307 | 0.130 |
Why?
| Chromosomes, Human, Y | 1 | 2015 | 20 | 0.130 |
Why?
| Factor XII | 1 | 2015 | 6 | 0.130 |
Why?
| Algorithms | 3 | 2021 | 1614 | 0.120 |
Why?
| Gastrointestinal Microbiome | 1 | 2023 | 641 | 0.120 |
Why?
| Disease | 1 | 2016 | 94 | 0.120 |
Why?
| Receptors, Neurokinin-3 | 1 | 2015 | 7 | 0.120 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 757 | 0.120 |
Why?
| Microbiota | 1 | 2023 | 724 | 0.120 |
Why?
| Cross-Sectional Studies | 8 | 2021 | 5045 | 0.120 |
Why?
| Laminin | 1 | 2015 | 68 | 0.120 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 76 | 0.120 |
Why?
| Calcium-Binding Proteins | 2 | 2013 | 209 | 0.120 |
Why?
| Motor Activity | 2 | 2013 | 669 | 0.120 |
Why?
| Cholesterol, LDL | 2 | 2014 | 357 | 0.120 |
Why?
| Gene-Environment Interaction | 1 | 2016 | 185 | 0.120 |
Why?
| Immunotherapy | 1 | 2019 | 589 | 0.120 |
Why?
| Menarche | 1 | 2015 | 59 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 25 | 0.120 |
Why?
| Chromosomes, Human, Pair 5 | 2 | 2012 | 29 | 0.120 |
Why?
| Chromosomes, Human, Pair 12 | 2 | 2019 | 21 | 0.120 |
Why?
| Apolipoproteins A | 1 | 2014 | 19 | 0.120 |
Why?
| Energy Intake | 1 | 2017 | 454 | 0.120 |
Why?
| Immunoglobulins | 1 | 2015 | 158 | 0.120 |
Why?
| Epistasis, Genetic | 1 | 2015 | 70 | 0.120 |
Why?
| Energy Metabolism | 2 | 2017 | 833 | 0.120 |
Why?
| Membrane Proteins | 3 | 2016 | 1109 | 0.120 |
Why?
| Thrombin | 1 | 2015 | 144 | 0.120 |
Why?
| Africa | 2 | 2020 | 99 | 0.110 |
Why?
| Insulin Resistance | 2 | 2021 | 1164 | 0.110 |
Why?
| Anemia, Sickle Cell | 1 | 2018 | 254 | 0.110 |
Why?
| DNA, Mitochondrial | 1 | 2015 | 190 | 0.110 |
Why?
| CD36 Antigens | 1 | 2014 | 35 | 0.110 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 189 | 0.110 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2013 | 28 | 0.110 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2013 | 19 | 0.110 |
Why?
| Penetrance | 2 | 2015 | 27 | 0.110 |
Why?
| RNA, Long Noncoding | 1 | 2016 | 178 | 0.110 |
Why?
| Residence Characteristics | 1 | 2016 | 326 | 0.110 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 392 | 0.110 |
Why?
| Philippines | 5 | 2011 | 49 | 0.110 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1562 | 0.110 |
Why?
| Diabetes, Gestational | 1 | 2017 | 308 | 0.110 |
Why?
| Time Factors | 6 | 2021 | 6505 | 0.100 |
Why?
| Blood Cells | 1 | 2012 | 38 | 0.100 |
Why?
| Periodontium | 1 | 2012 | 3 | 0.100 |
Why?
| Meta-Analysis as Topic | 4 | 2014 | 169 | 0.100 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 250 | 0.100 |
Why?
| Autoantigens | 1 | 2015 | 416 | 0.100 |
Why?
| Promoter Regions, Genetic | 3 | 2006 | 1199 | 0.100 |
Why?
| Glutathione Transferase | 1 | 2012 | 101 | 0.100 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2019 | 592 | 0.100 |
Why?
| Interleukin-18 | 1 | 2013 | 236 | 0.100 |
Why?
| RNA-Binding Proteins | 1 | 2015 | 389 | 0.090 |
Why?
| Methyltransferases | 1 | 2012 | 70 | 0.090 |
Why?
| Receptors, Immunologic | 2 | 2003 | 216 | 0.090 |
Why?
| Arsenic | 1 | 2012 | 66 | 0.090 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2011 | 29 | 0.090 |
Why?
| Factor VII | 1 | 2011 | 22 | 0.090 |
Why?
| Metagenome | 1 | 2012 | 140 | 0.090 |
Why?
| Sample Size | 3 | 2021 | 115 | 0.090 |
Why?
| Logistic Models | 3 | 2012 | 1980 | 0.090 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2017 | 564 | 0.090 |
Why?
| Chromosomes, Human, Pair 22 | 2 | 2010 | 41 | 0.090 |
Why?
| Homozygote | 3 | 2012 | 193 | 0.090 |
Why?
| Kininogen, Low-Molecular-Weight | 1 | 2010 | 2 | 0.090 |
Why?
| Kininogen, High-Molecular-Weight | 1 | 2010 | 3 | 0.090 |
Why?
| Kininogens | 1 | 2010 | 6 | 0.090 |
Why?
| Mathematical Computing | 1 | 2010 | 11 | 0.090 |
Why?
| Erythrocytes | 1 | 2016 | 673 | 0.090 |
Why?
| Breast Neoplasms | 4 | 2004 | 2135 | 0.090 |
Why?
| Cystic Fibrosis | 2 | 2011 | 1049 | 0.090 |
Why?
| Indians, North American | 1 | 2016 | 599 | 0.090 |
Why?
| TCF Transcription Factors | 1 | 2010 | 16 | 0.090 |
Why?
| Population | 1 | 2010 | 33 | 0.090 |
Why?
| Nandrolone | 1 | 2010 | 3 | 0.090 |
Why?
| Malawi | 1 | 2010 | 48 | 0.090 |
Why?
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2010 | 4 | 0.090 |
Why?
| Ethinyl Estradiol | 1 | 2010 | 17 | 0.090 |
Why?
| Family | 4 | 2006 | 649 | 0.090 |
Why?
| Molecular Epidemiology | 2 | 2022 | 63 | 0.080 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2010 | 31 | 0.080 |
Why?
| Carbohydrate Metabolism | 1 | 2010 | 60 | 0.080 |
Why?
| RNA Helicases | 1 | 2009 | 23 | 0.080 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2016 | 23 | 0.080 |
Why?
| Heterozygote | 3 | 2016 | 269 | 0.080 |
Why?
| Peptidyl-Dipeptidase A | 2 | 2009 | 50 | 0.080 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 150 | 0.080 |
Why?
| WW Domain-Containing Oxidoreductase | 1 | 2009 | 2 | 0.080 |
Why?
| Heart Failure | 1 | 2022 | 2145 | 0.080 |
Why?
| Urinary Bladder Neoplasms | 1 | 2012 | 226 | 0.080 |
Why?
| Myocardial Infarction | 2 | 2014 | 1015 | 0.080 |
Why?
| Maxilla | 1 | 2009 | 33 | 0.080 |
Why?
| Cadherins | 1 | 2010 | 188 | 0.080 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2009 | 48 | 0.080 |
Why?
| Cephalometry | 1 | 2009 | 31 | 0.080 |
Why?
| Genes, Recessive | 4 | 2004 | 76 | 0.080 |
Why?
| Glucose Intolerance | 1 | 2010 | 142 | 0.080 |
Why?
| Collagen Type II | 1 | 2009 | 47 | 0.080 |
Why?
| Genes, Homeobox | 1 | 2009 | 50 | 0.080 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 88 | 0.080 |
Why?
| Stroke | 2 | 2015 | 1073 | 0.080 |
Why?
| Oxidoreductases | 1 | 2009 | 89 | 0.080 |
Why?
| Prostate-Specific Antigen | 2 | 2007 | 162 | 0.080 |
Why?
| Psoriasis | 2 | 2002 | 85 | 0.070 |
Why?
| Adolescent Behavior | 1 | 2013 | 505 | 0.070 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 102 | 0.070 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 8 | 0.070 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 29 | 0.070 |
Why?
| Environmental Exposure | 1 | 2012 | 461 | 0.070 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2008 | 29 | 0.070 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 102 | 0.070 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 84 | 0.070 |
Why?
| Interleukin-6 | 2 | 2009 | 715 | 0.070 |
Why?
| HLA-DR2 Antigen | 1 | 2007 | 7 | 0.070 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 127 | 0.070 |
Why?
| Genes, Dominant | 2 | 2004 | 91 | 0.070 |
Why?
| Germany | 3 | 2020 | 98 | 0.070 |
Why?
| Prediabetic State | 1 | 2010 | 245 | 0.070 |
Why?
| BRCA1 Protein | 1 | 2007 | 65 | 0.070 |
Why?
| Europe | 1 | 2008 | 360 | 0.070 |
Why?
| HLA-DR3 Antigen | 1 | 2007 | 80 | 0.070 |
Why?
| Neural Cell Adhesion Molecules | 1 | 2006 | 29 | 0.070 |
Why?
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 12 | 0.070 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 487 | 0.070 |
Why?
| Liver Diseases | 1 | 2009 | 287 | 0.070 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 11 | 0.070 |
Why?
| Mixed Function Oxygenases | 1 | 2006 | 36 | 0.060 |
Why?
| Transcription Factors | 3 | 2012 | 1635 | 0.060 |
Why?
| Sex Factors | 5 | 2017 | 1951 | 0.060 |
Why?
| Genes, Lethal | 1 | 2005 | 29 | 0.060 |
Why?
| Pimozide | 2 | 1976 | 4 | 0.060 |
Why?
| Genomic Imprinting | 1 | 2005 | 33 | 0.060 |
Why?
| Infant | 5 | 2010 | 9001 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2014 | 4874 | 0.060 |
Why?
| Genomics | 2 | 2007 | 715 | 0.060 |
Why?
| National Longitudinal Study of Adolescent Health | 2 | 2016 | 9 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2019 | 856 | 0.060 |
Why?
| Warfarin | 1 | 2006 | 145 | 0.060 |
Why?
| Chromosomes | 1 | 2005 | 101 | 0.060 |
Why?
| Population Groups | 1 | 2025 | 58 | 0.060 |
Why?
| Multigene Family | 1 | 2005 | 198 | 0.060 |
Why?
| Serum | 1 | 2005 | 57 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 420 | 0.060 |
Why?
| Survival Analysis | 2 | 2020 | 1265 | 0.060 |
Why?
| Immunoglobulin E | 2 | 2003 | 329 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 715 | 0.060 |
Why?
| Platelet Count | 2 | 2016 | 82 | 0.060 |
Why?
| Siblings | 3 | 2010 | 215 | 0.060 |
Why?
| Hematocrit | 2 | 2016 | 93 | 0.060 |
Why?
| Receptor, Melanocortin, Type 4 | 2 | 2016 | 14 | 0.060 |
Why?
| Fertility | 1 | 2005 | 159 | 0.060 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2007 | 245 | 0.060 |
Why?
| Neoplasm Invasiveness | 1 | 2006 | 478 | 0.060 |
Why?
| Michigan | 3 | 2012 | 103 | 0.060 |
Why?
| Apolipoproteins | 1 | 2023 | 38 | 0.050 |
Why?
| Physical Fitness | 1 | 2005 | 203 | 0.050 |
Why?
| Meiosis | 1 | 2004 | 63 | 0.050 |
Why?
| Syndrome | 3 | 2017 | 336 | 0.050 |
Why?
| DNA Mutational Analysis | 3 | 2016 | 385 | 0.050 |
Why?
| Intermediate Filaments | 1 | 2023 | 27 | 0.050 |
Why?
| Hypersensitivity, Immediate | 1 | 2003 | 43 | 0.050 |
Why?
| Neurofilament Proteins | 1 | 2023 | 43 | 0.050 |
Why?
| Societies, Medical | 1 | 2007 | 744 | 0.050 |
Why?
| Asialoglycoprotein Receptor | 1 | 2022 | 4 | 0.050 |
Why?
| Insulin | 4 | 2021 | 2316 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2003 | 117 | 0.050 |
Why?
| Tropomyosin | 1 | 2002 | 12 | 0.050 |
Why?
| Pilot Projects | 2 | 2022 | 1568 | 0.050 |
Why?
| Cognition Disorders | 1 | 2007 | 498 | 0.050 |
Why?
| Endoribonucleases | 1 | 2003 | 70 | 0.050 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 59 | 0.050 |
Why?
| Osteoarthritis, Knee | 1 | 2005 | 239 | 0.050 |
Why?
| Hemoglobins | 2 | 2016 | 337 | 0.050 |
Why?
| Inflammation | 2 | 2013 | 2666 | 0.050 |
Why?
| Genome | 1 | 2004 | 277 | 0.050 |
Why?
| Disease Progression | 2 | 2020 | 2604 | 0.050 |
Why?
| Mastectomy, Segmental | 1 | 2002 | 85 | 0.050 |
Why?
| Risk | 3 | 2010 | 853 | 0.050 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2002 | 82 | 0.050 |
Why?
| Amino Acid Substitution | 3 | 2012 | 281 | 0.050 |
Why?
| Data Interpretation, Statistical | 2 | 2015 | 335 | 0.050 |
Why?
| Anticoagulants | 1 | 2006 | 634 | 0.050 |
Why?
| Causality | 1 | 2021 | 116 | 0.050 |
Why?
| Biomarkers, Tumor | 2 | 2006 | 1179 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2008 | 894 | 0.050 |
Why?
| alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
| Tripartite Motif Proteins | 1 | 2020 | 31 | 0.040 |
Why?
| Kidney Function Tests | 1 | 2021 | 145 | 0.040 |
Why?
| Drosophila Proteins | 1 | 2002 | 187 | 0.040 |
Why?
| HLA Antigens | 1 | 2002 | 234 | 0.040 |
Why?
| Platelet Factor 4 | 1 | 1980 | 33 | 0.040 |
Why?
| Mitogens | 1 | 1980 | 58 | 0.040 |
Why?
| Disease Susceptibility | 4 | 2009 | 332 | 0.040 |
Why?
| Dioxygenases | 1 | 2020 | 29 | 0.040 |
Why?
| Growth Substances | 1 | 1980 | 150 | 0.040 |
Why?
| Codon, Nonsense | 2 | 2015 | 39 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2020 | 53 | 0.040 |
Why?
| Blood Coagulation Factors | 1 | 1980 | 53 | 0.040 |
Why?
| Cell Adhesion Molecules | 2 | 2017 | 173 | 0.040 |
Why?
| Africa, Western | 1 | 2020 | 17 | 0.040 |
Why?
| Body Weight | 3 | 2010 | 933 | 0.040 |
Why?
| Tobacco Smoke Pollution | 1 | 2003 | 229 | 0.040 |
Why?
| Neoplasm Staging | 2 | 2020 | 1292 | 0.040 |
Why?
| Calcinosis | 1 | 2002 | 230 | 0.040 |
Why?
| Models, Statistical | 1 | 2004 | 622 | 0.040 |
Why?
| Diabetic Nephropathies | 1 | 2003 | 279 | 0.040 |
Why?
| von Willebrand Factor | 1 | 2020 | 69 | 0.040 |
Why?
| Albuminuria | 1 | 2020 | 181 | 0.040 |
Why?
| Carotid Intima-Media Thickness | 1 | 2020 | 90 | 0.040 |
Why?
| Bayes Theorem | 2 | 2016 | 373 | 0.040 |
Why?
| Exons | 3 | 2006 | 339 | 0.040 |
Why?
| Idarubicin | 1 | 2019 | 5 | 0.040 |
Why?
| Autoantibodies | 1 | 2007 | 1464 | 0.040 |
Why?
| Neoplasm Grading | 1 | 2020 | 285 | 0.040 |
Why?
| Abdomen | 1 | 2019 | 118 | 0.040 |
Why?
| Cognition | 1 | 2006 | 1110 | 0.040 |
Why?
| Infant, Newborn | 3 | 2017 | 5740 | 0.040 |
Why?
| Induction Chemotherapy | 1 | 2019 | 70 | 0.040 |
Why?
| Creatinine | 1 | 2020 | 480 | 0.040 |
Why?
| Etoposide | 1 | 2019 | 148 | 0.040 |
Why?
| Chromosome Breakage | 1 | 1998 | 21 | 0.040 |
Why?
| Brain | 3 | 2007 | 2624 | 0.040 |
Why?
| alpha-Thalassemia | 1 | 2018 | 4 | 0.040 |
Why?
| Erythrocytes, Abnormal | 1 | 2018 | 11 | 0.040 |
Why?
| Pregnancy | 3 | 2021 | 6373 | 0.040 |
Why?
| Endothelial Protein C Receptor | 1 | 2017 | 5 | 0.040 |
Why?
| Treatment Outcome | 3 | 2019 | 10162 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 647 | 0.040 |
Why?
| Prostate | 2 | 2012 | 180 | 0.040 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2017 | 3 | 0.040 |
Why?
| Research Design | 1 | 2004 | 1036 | 0.040 |
Why?
| Azacitidine | 1 | 2019 | 139 | 0.040 |
Why?
| Kidney Failure, Chronic | 1 | 2003 | 541 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2000 | 297 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 433 | 0.040 |
Why?
| Homeostasis | 1 | 2021 | 606 | 0.040 |
Why?
| Cytokines | 1 | 2005 | 1994 | 0.030 |
Why?
| Hematopoietic Stem Cells | 1 | 2020 | 379 | 0.030 |
Why?
| DNA | 2 | 2022 | 1394 | 0.030 |
Why?
| ADAMTS Proteins | 1 | 2017 | 5 | 0.030 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 3 | 0.030 |
Why?
| NADPH Oxidase 4 | 1 | 2017 | 7 | 0.030 |
Why?
| Procollagen N-Endopeptidase | 1 | 2017 | 8 | 0.030 |
Why?
| Somatomedins | 1 | 2017 | 28 | 0.030 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 14 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2018 | 169 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 633 | 0.030 |
Why?
| Lymph Nodes | 1 | 2019 | 466 | 0.030 |
Why?
| Body Burden | 1 | 2016 | 7 | 0.030 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 42 | 0.030 |
Why?
| Interferon Regulatory Factors | 1 | 2017 | 33 | 0.030 |
Why?
| Statistics as Topic | 1 | 2017 | 304 | 0.030 |
Why?
| Autopsy | 1 | 1997 | 92 | 0.030 |
Why?
| Precision Medicine | 1 | 2020 | 386 | 0.030 |
Why?
| NADPH Oxidases | 1 | 2017 | 107 | 0.030 |
Why?
| Muridae | 1 | 1996 | 5 | 0.030 |
Why?
| Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| Allelic Imbalance | 1 | 2016 | 8 | 0.030 |
Why?
| Transcription Factor AP-2 | 1 | 2016 | 83 | 0.030 |
Why?
| Geographic Information Systems | 1 | 2016 | 42 | 0.030 |
Why?
| Glycosaminoglycans | 1 | 2017 | 84 | 0.030 |
Why?
| Drosophila | 1 | 2017 | 142 | 0.030 |
Why?
| Erythrocyte Indices | 1 | 2016 | 27 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2002 | 958 | 0.030 |
Why?
| Transportation | 1 | 2016 | 50 | 0.030 |
Why?
| Blood Cell Count | 1 | 2016 | 52 | 0.030 |
Why?
| Proteoglycans | 1 | 2017 | 109 | 0.030 |
Why?
| Biopsy | 1 | 2020 | 1079 | 0.030 |
Why?
| Proteolysis | 1 | 2017 | 162 | 0.030 |
Why?
| Homicide | 1 | 1997 | 60 | 0.030 |
Why?
| Glucose | 1 | 2021 | 983 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 157 | 0.030 |
Why?
| Adipose Tissue | 1 | 2020 | 589 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 293 | 0.030 |
Why?
| Chromosomes, Human | 2 | 2009 | 41 | 0.030 |
Why?
| Electrocardiography | 1 | 2019 | 608 | 0.030 |
Why?
| Parents | 1 | 2004 | 1307 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2021 | 2516 | 0.030 |
Why?
| Diet | 1 | 2023 | 1204 | 0.030 |
Why?
| Genes, X-Linked | 1 | 2015 | 17 | 0.030 |
Why?
| Hedgehog Proteins | 1 | 2017 | 188 | 0.030 |
Why?
| Normal Distribution | 1 | 2015 | 21 | 0.030 |
Why?
| Prevalence | 2 | 2013 | 2553 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Apolipoprotein A-V | 1 | 2014 | 3 | 0.030 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 372 | 0.030 |
Why?
| Hypogonadism | 1 | 2015 | 84 | 0.030 |
Why?
| Amides | 1 | 2015 | 90 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 502 | 0.030 |
Why?
| Glycoproteins | 1 | 2017 | 337 | 0.030 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 39 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 435 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2012 | 2822 | 0.030 |
Why?
| Environment | 1 | 2016 | 345 | 0.030 |
Why?
| Circadian Rhythm | 1 | 2018 | 412 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 373 | 0.030 |
Why?
| Sex Distribution | 1 | 2015 | 358 | 0.030 |
Why?
| Echocardiography | 1 | 2017 | 624 | 0.030 |
Why?
| Birth Weight | 1 | 2017 | 499 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 91 | 0.030 |
Why?
| Genetic Code | 1 | 2014 | 20 | 0.030 |
Why?
| Proprotein Convertases | 1 | 2014 | 15 | 0.030 |
Why?
| Mothers | 2 | 2010 | 729 | 0.030 |
Why?
| Child, Preschool | 4 | 2009 | 10487 | 0.030 |
Why?
| Amino Acid Sequence | 2 | 2012 | 2044 | 0.030 |
Why?
| Proprotein Convertase 9 | 1 | 2014 | 68 | 0.030 |
Why?
| RNA Interference | 1 | 2015 | 441 | 0.030 |
Why?
| Lipase | 1 | 2014 | 64 | 0.030 |
Why?
| Video Games | 1 | 2013 | 22 | 0.030 |
Why?
| Serine Endopeptidases | 1 | 2014 | 118 | 0.030 |
Why?
| Scavenger Receptors, Class A | 2 | 2003 | 10 | 0.030 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 1993 | 51 | 0.030 |
Why?
| Receptors, Scavenger | 2 | 2003 | 21 | 0.030 |
Why?
| Hexosyltransferases | 1 | 2012 | 5 | 0.030 |
Why?
| Television | 1 | 2013 | 74 | 0.030 |
Why?
| International Agencies | 1 | 2012 | 29 | 0.030 |
Why?
| Confidence Intervals | 2 | 2003 | 316 | 0.030 |
Why?
| Ambulatory Care | 2 | 1976 | 504 | 0.030 |
Why?
| Prevotella nigrescens | 1 | 2012 | 1 | 0.030 |
Why?
| Vesicle-Associated Membrane Protein 3 | 1 | 2012 | 2 | 0.030 |
Why?
| Prevotella intermedia | 1 | 2012 | 2 | 0.030 |
Why?
| Campylobacter rectus | 1 | 2012 | 2 | 0.030 |
Why?
| Treponema denticola | 1 | 2012 | 2 | 0.030 |
Why?
| Fusobacterium nucleatum | 1 | 2012 | 3 | 0.030 |
Why?
| Bacteroides | 1 | 2012 | 19 | 0.020 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 20 | 0.020 |
Why?
| Aggregatibacter actinomycetemcomitans | 1 | 2012 | 20 | 0.020 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 39 | 0.020 |
Why?
| Fatty Acids | 1 | 2015 | 417 | 0.020 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2012 | 14 | 0.020 |
Why?
| Hematologic Diseases | 1 | 2012 | 60 | 0.020 |
Why?
| Triglycerides | 1 | 2014 | 523 | 0.020 |
Why?
| Nuclear Family | 2 | 2003 | 51 | 0.020 |
Why?
| F-Box Proteins | 1 | 2012 | 26 | 0.020 |
Why?
| Bacterial Load | 1 | 2012 | 66 | 0.020 |
Why?
| Neuropsychological Tests | 2 | 2007 | 1005 | 0.020 |
Why?
| Interleukin-33 | 1 | 2012 | 48 | 0.020 |
Why?
| Fetal Diseases | 1 | 1993 | 156 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2012 | 182 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2012 | 369 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2012 | 188 | 0.020 |
Why?
| Dyslipidemias | 1 | 2014 | 176 | 0.020 |
Why?
| Prenatal Diagnosis | 1 | 1993 | 190 | 0.020 |
Why?
| Islets of Langerhans | 1 | 2018 | 790 | 0.020 |
Why?
| DNA Primers | 1 | 2012 | 510 | 0.020 |
Why?
| Crosses, Genetic | 2 | 2005 | 142 | 0.020 |
Why?
| Liver | 1 | 2020 | 1827 | 0.020 |
Why?
| Drinking Water | 1 | 2012 | 75 | 0.020 |
Why?
| Southeastern United States | 1 | 2010 | 34 | 0.020 |
Why?
| Finland | 2 | 2001 | 90 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2012 | 153 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2012 | 324 | 0.020 |
Why?
| Signal Transduction | 2 | 2015 | 4825 | 0.020 |
Why?
| Interleukins | 1 | 2012 | 241 | 0.020 |
Why?
| Recombination, Genetic | 3 | 1998 | 190 | 0.020 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 22 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2013 | 424 | 0.020 |
Why?
| Waist Circumference | 1 | 2010 | 138 | 0.020 |
Why?
| Hypertriglyceridemia | 1 | 2010 | 39 | 0.020 |
Why?
| Fanconi Anemia Complementation Group Proteins | 1 | 2009 | 6 | 0.020 |
Why?
| Menstruation | 1 | 2010 | 44 | 0.020 |
Why?
| Glutathione S-Transferase pi | 1 | 2009 | 9 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2014 | 1668 | 0.020 |
Why?
| Mannose-Binding Lectin | 1 | 2009 | 22 | 0.020 |
Why?
| Trans-Activators | 1 | 2012 | 384 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 498 | 0.020 |
Why?
| Animals | 6 | 2017 | 34647 | 0.020 |
Why?
| C-Peptide | 1 | 2010 | 163 | 0.020 |
Why?
| Hypertension, Portal | 1 | 2009 | 60 | 0.020 |
Why?
| Body Composition | 1 | 2013 | 644 | 0.020 |
Why?
| Twins | 1 | 2010 | 249 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2012 | 1499 | 0.020 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 39 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2010 | 356 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 154 | 0.020 |
Why?
| Fanconi Anemia Complementation Group N Protein | 1 | 2008 | 5 | 0.020 |
Why?
| Puberty | 1 | 2009 | 143 | 0.020 |
Why?
| Educational Status | 1 | 2010 | 470 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 39 | 0.020 |
Why?
| Intracranial Arteriosclerosis | 2 | 2006 | 7 | 0.020 |
Why?
| Nutritional Status | 1 | 2010 | 326 | 0.020 |
Why?
| Fathers | 1 | 2008 | 48 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 715 | 0.020 |
Why?
| Longevity | 1 | 2009 | 150 | 0.020 |
Why?
| Monte Carlo Method | 2 | 2002 | 140 | 0.020 |
Why?
| Liver Cirrhosis | 1 | 2009 | 279 | 0.020 |
Why?
| Isoenzymes | 1 | 2008 | 302 | 0.020 |
Why?
| Tunica Intima | 1 | 2006 | 80 | 0.020 |
Why?
| Vitamin K Epoxide Reductases | 1 | 2006 | 12 | 0.020 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2006 | 20 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2006 | 9 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 10 | 0.020 |
Why?
| Genetic Heterogeneity | 1 | 2006 | 58 | 0.020 |
Why?
| International Normalized Ratio | 1 | 2006 | 45 | 0.020 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 42 | 0.020 |
Why?
| Sweden | 1 | 2006 | 92 | 0.020 |
Why?
| Embolism | 1 | 2006 | 41 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 1996 | 5281 | 0.020 |
Why?
| Arterial Occlusive Diseases | 1 | 2006 | 80 | 0.020 |
Why?
| Weight Lifting | 1 | 2005 | 34 | 0.020 |
Why?
| Carotid Arteries | 1 | 2006 | 194 | 0.020 |
Why?
| DNA Probes | 2 | 1997 | 61 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2005 | 402 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 83 | 0.010 |
Why?
| Statistical Distributions | 1 | 2004 | 8 | 0.010 |
Why?
| DNA Replication | 1 | 2006 | 225 | 0.010 |
Why?
| Adult Children | 1 | 2003 | 23 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1273 | 0.010 |
Why?
| Radiography | 1 | 2006 | 795 | 0.010 |
Why?
| Likelihood Functions | 1 | 2003 | 137 | 0.010 |
Why?
| Consanguinity | 2 | 1994 | 47 | 0.010 |
Why?
| Skin Tests | 1 | 2003 | 100 | 0.010 |
Why?
| Systole | 1 | 2003 | 190 | 0.010 |
Why?
| Minisatellite Repeats | 1 | 2003 | 40 | 0.010 |
Why?
| X-ray Repair Cross Complementing Protein 1 | 1 | 2003 | 14 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 69 | 0.010 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2004 | 488 | 0.010 |
Why?
| Mice | 4 | 2005 | 16620 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2003 | 139 | 0.010 |
Why?
| Heart Diseases | 1 | 2006 | 347 | 0.010 |
Why?
| Cell Line | 2 | 2002 | 2741 | 0.010 |
Why?
| RNA, Neoplasm | 1 | 2002 | 87 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2010 | 3021 | 0.010 |
Why?
| Transduction, Genetic | 1 | 2002 | 128 | 0.010 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2002 | 54 | 0.010 |
Why?
| Carcinoma, Lobular | 1 | 2002 | 48 | 0.010 |
Why?
| Radiotherapy, Adjuvant | 1 | 2002 | 210 | 0.010 |
Why?
| Reference Values | 1 | 2003 | 780 | 0.010 |
Why?
| Phylogeny | 1 | 2005 | 849 | 0.010 |
Why?
| Depressive Disorder, Major | 2 | 1976 | 344 | 0.010 |
Why?
| Tamoxifen | 1 | 2002 | 200 | 0.010 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2002 | 158 | 0.010 |
Why?
| Chemotherapy, Adjuvant | 1 | 2002 | 381 | 0.010 |
Why?
| Base Sequence | 2 | 1995 | 2137 | 0.010 |
Why?
| Isoelectric Point | 1 | 1980 | 23 | 0.010 |
Why?
| Walking | 1 | 2005 | 497 | 0.010 |
Why?
| Matched-Pair Analysis | 1 | 2000 | 40 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 777 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 930 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1187 | 0.010 |
Why?
| Biological Assay | 1 | 1980 | 118 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2002 | 837 | 0.010 |
Why?
| Internet | 1 | 2004 | 613 | 0.010 |
Why?
| Cyclothymic Disorder | 2 | 1976 | 4 | 0.010 |
Why?
| Renal Dialysis | 1 | 2003 | 423 | 0.010 |
Why?
| Ovarian Neoplasms | 1 | 2004 | 487 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 1623 | 0.010 |
Why?
| Aging | 1 | 2009 | 1755 | 0.010 |
Why?
| Founder Effect | 1 | 1998 | 12 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2006 | 2719 | 0.010 |
Why?
| Retrospective Studies | 2 | 2006 | 14471 | 0.010 |
Why?
| Depression | 2 | 1976 | 1292 | 0.010 |
Why?
| Death Certificates | 1 | 1997 | 30 | 0.010 |
Why?
| Accidents | 1 | 1997 | 39 | 0.010 |
Why?
| Malpractice | 1 | 1997 | 38 | 0.010 |
Why?
| Dibenzocycloheptenes | 1 | 1976 | 2 | 0.010 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 1996 | 65 | 0.010 |
Why?
| Fluspirilene | 1 | 1976 | 1 | 0.010 |
Why?
| Penfluridol | 1 | 1976 | 1 | 0.010 |
Why?
| Fluphenazine | 1 | 1976 | 5 | 0.010 |
Why?
| Therapeutic Equivalency | 1 | 1976 | 21 | 0.010 |
Why?
| Nail-Patella Syndrome | 1 | 1976 | 1 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1976 | 37 | 0.010 |
Why?
| Haloperidol | 1 | 1976 | 32 | 0.010 |
Why?
| ABO Blood-Group System | 1 | 1976 | 39 | 0.010 |
Why?
| Diagnostic Errors | 1 | 1997 | 161 | 0.010 |
Why?
| Costa Rica | 1 | 1995 | 16 | 0.010 |
Why?
| Paranoid Disorders | 1 | 1975 | 2 | 0.010 |
Why?
| Hallucinations | 1 | 1975 | 29 | 0.010 |
Why?
| Macrophages | 1 | 2002 | 1464 | 0.010 |
Why?
| Cause of Death | 1 | 1997 | 392 | 0.010 |
Why?
| Genes | 1 | 1995 | 226 | 0.010 |
Why?
| Long-Term Care | 1 | 1975 | 91 | 0.010 |
Why?
| Delayed-Action Preparations | 1 | 1975 | 170 | 0.010 |
Why?
| Hybrid Cells | 1 | 1993 | 50 | 0.010 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 1993 | 15 | 0.010 |
Why?
| DNA, Complementary | 1 | 1993 | 267 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1993 | 291 | 0.010 |
Why?
| Cells, Cultured | 1 | 1980 | 4017 | 0.010 |
Why?
| Turkey | 1 | 1992 | 19 | 0.010 |
Why?
| Chromosome Banding | 1 | 1992 | 21 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 68 | 0.010 |
Why?
| Ataxia | 1 | 1992 | 41 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2002 | 2517 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 1975 | 1016 | 0.010 |
Why?
| Microcephaly | 1 | 1992 | 87 | 0.010 |
Why?
| Suicide | 1 | 1997 | 577 | 0.010 |
Why?
| Wounds and Injuries | 1 | 1997 | 707 | 0.010 |
Why?
| Cysticercosis | 1 | 1969 | 3 | 0.000 |
Why?
| Cataract | 1 | 1992 | 208 | 0.000 |
Why?
| Diagnosis, Differential | 1 | 1992 | 1412 | 0.000 |
Why?
| Brain Diseases | 1 | 1969 | 137 | 0.000 |
Why?
| Adjustment Disorders | 1 | 1976 | 5 | 0.000 |
Why?
| Psychophysiologic Disorders | 1 | 1976 | 10 | 0.000 |
Why?
| Neurocognitive Disorders | 1 | 1976 | 22 | 0.000 |
Why?
| Computers | 1 | 1976 | 65 | 0.000 |
Why?
|
|
Lange's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|